

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * somatic diversification of immune receptors via somatic mutation (GO:0002566) | 8.22160719 |
| 2 | * somatic hypermutation of immunoglobulin genes (GO:0016446) | 8.22160719 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 8.07223471 |
| 4 | B cell receptor signaling pathway (GO:0050853) | 7.49528468 |
| 5 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 6.43676107 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.41517826 |
| 7 | cellular response to zinc ion (GO:0071294) | 6.36637899 |
| 8 | regulation of germinal center formation (GO:0002634) | 6.03684956 |
| 9 | telomere maintenance via semi-conservative replication (GO:0032201) | 5.37875067 |
| 10 | negative regulation of B cell apoptotic process (GO:0002903) | 5.33673220 |
| 11 | * cytidine metabolic process (GO:0046087) | 5.09113675 |
| 12 | * cytidine catabolic process (GO:0006216) | 5.09113675 |
| 13 | * cytidine deamination (GO:0009972) | 5.09113675 |
| 14 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 4.81591900 |
| 15 | B cell proliferation (GO:0042100) | 4.81358460 |
| 16 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.78966245 |
| 17 | germinal center formation (GO:0002467) | 4.78337941 |
| 18 | regulation of B cell apoptotic process (GO:0002902) | 4.71609866 |
| 19 | telomere maintenance via recombination (GO:0000722) | 4.71566903 |
| 20 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.60408548 |
| 21 | DNA strand elongation (GO:0022616) | 4.51518514 |
| 22 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.47164781 |
| 23 | T cell lineage commitment (GO:0002360) | 4.44254188 |
| 24 | mitotic recombination (GO:0006312) | 4.42851937 |
| 25 | protein localization to kinetochore (GO:0034501) | 4.40933619 |
| 26 | regulation of B cell differentiation (GO:0045577) | 4.39005828 |
| 27 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.19861822 |
| 28 | mitotic sister chromatid segregation (GO:0000070) | 4.18188178 |
| 29 | regulation of B cell proliferation (GO:0030888) | 4.15569545 |
| 30 | DNA deamination (GO:0045006) | 4.14769483 |
| 31 | * somatic diversification of immunoglobulins (GO:0016445) | 4.09750680 |
| 32 | positive regulation of protein homooligomerization (GO:0032464) | 4.00082363 |
| 33 | positive thymic T cell selection (GO:0045059) | 3.96157501 |
| 34 | telomere maintenance via telomere lengthening (GO:0010833) | 3.89012792 |
| 35 | negative thymic T cell selection (GO:0045060) | 3.88002679 |
| 36 | positive regulation of defense response to virus by host (GO:0002230) | 3.82094383 |
| 37 | DNA replication checkpoint (GO:0000076) | 3.82084830 |
| 38 | sister chromatid segregation (GO:0000819) | 3.81626617 |
| 39 | B cell homeostasis (GO:0001782) | 3.77388403 |
| 40 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.77284305 |
| 41 | immunoglobulin mediated immune response (GO:0016064) | 3.77157534 |
| 42 | base-excision repair (GO:0006284) | 3.73058839 |
| 43 | positive regulation of B cell proliferation (GO:0030890) | 3.68216691 |
| 44 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.65308385 |
| 45 | mitotic chromosome condensation (GO:0007076) | 3.64843965 |
| 46 | B cell mediated immunity (GO:0019724) | 3.64524058 |
| 47 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.64191379 |
| 48 | complement activation, classical pathway (GO:0006958) | 3.62543240 |
| 49 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.61207252 |
| 50 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.55635527 |
| 51 | polyketide metabolic process (GO:0030638) | 3.53064623 |
| 52 | doxorubicin metabolic process (GO:0044598) | 3.53064623 |
| 53 | daunorubicin metabolic process (GO:0044597) | 3.53064623 |
| 54 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.52234388 |
| 55 | negative T cell selection (GO:0043383) | 3.52156607 |
| 56 | protein localization to chromosome, centromeric region (GO:0071459) | 3.49667570 |
| 57 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.49604746 |
| 58 | negative regulation of phagocytosis (GO:0050765) | 3.48384227 |
| 59 | mature B cell differentiation (GO:0002335) | 3.47821480 |
| 60 | positive regulation of macrophage cytokine production (GO:0060907) | 3.46967258 |
| 61 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.46522445 |
| 62 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.46522445 |
| 63 | tryptophan metabolic process (GO:0006568) | 3.39948574 |
| 64 | positive regulation of humoral immune response (GO:0002922) | 3.36104326 |
| 65 | positive regulation of protein homodimerization activity (GO:0090073) | 3.35544860 |
| 66 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.34137225 |
| 67 | endoderm formation (GO:0001706) | 3.34051832 |
| 68 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.33498111 |
| 69 | formation of translation preinitiation complex (GO:0001731) | 3.31132656 |
| 70 | cellular response to interleukin-15 (GO:0071350) | 3.29496482 |
| 71 | histamine secretion (GO:0001821) | 3.29094375 |
| 72 | T cell migration (GO:0072678) | 3.28591512 |
| 73 | regulation of histone H3-K27 methylation (GO:0061085) | 3.26715226 |
| 74 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.25242875 |
| 75 | negative regulation of B cell mediated immunity (GO:0002713) | 3.25242875 |
| 76 | behavioral response to nicotine (GO:0035095) | 3.22455295 |
| 77 | natural killer cell mediated immunity (GO:0002228) | 3.22255398 |
| 78 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.22255398 |
| 79 | mature B cell differentiation involved in immune response (GO:0002313) | 3.21170631 |
| 80 | * B cell activation (GO:0042113) | 3.20485632 |
| 81 | DNA replication initiation (GO:0006270) | 3.20251181 |
| 82 | indolalkylamine metabolic process (GO:0006586) | 3.20151070 |
| 83 | positive regulation of interleukin-12 production (GO:0032735) | 3.19048126 |
| 84 | positive regulation of type 2 immune response (GO:0002830) | 3.11443840 |
| 85 | regulation of B cell activation (GO:0050864) | 3.09978408 |
| 86 | positive regulation of B cell differentiation (GO:0045579) | 3.09660453 |
| 87 | lymphocyte homeostasis (GO:0002260) | 3.08696053 |
| 88 | response to type I interferon (GO:0034340) | 3.07363538 |
| 89 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.06737344 |
| 90 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.05379778 |
| 91 | DNA unwinding involved in DNA replication (GO:0006268) | 3.04445580 |
| 92 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.03899715 |
| 93 | regulation of defense response to virus by host (GO:0050691) | 3.03771327 |
| 94 | thymic T cell selection (GO:0045061) | 3.03469440 |
| 95 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.01688228 |
| 96 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.00934474 |
| 97 | positive regulation of B cell mediated immunity (GO:0002714) | 3.00934474 |
| 98 | cellular response to type I interferon (GO:0071357) | 3.00734190 |
| 99 | type I interferon signaling pathway (GO:0060337) | 3.00734190 |
| 100 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.99918291 |
| 101 | * somatic diversification of immune receptors (GO:0002200) | 2.99794823 |
| 102 | positive regulation of B cell activation (GO:0050871) | 2.99566536 |
| 103 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.99419208 |
| 104 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.98635571 |
| 105 | positive regulation of interferon-alpha production (GO:0032727) | 2.98630828 |
| 106 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.98050191 |
| 107 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.97873371 |
| 108 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.97873371 |
| 109 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.97873371 |
| 110 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 2.97114611 |
| 111 | negative regulation of telomere maintenance (GO:0032205) | 2.97019500 |
| 112 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.96940925 |
| 113 | humoral immune response (GO:0006959) | 2.94853378 |
| 114 | telomere maintenance (GO:0000723) | 2.93637706 |
| 115 | positive regulation of antigen processing and presentation (GO:0002579) | 2.93599067 |
| 116 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.93133132 |
| 117 | telomere organization (GO:0032200) | 2.92808714 |
| 118 | * pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.92790581 |
| 119 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.91926197 |
| 120 | regulation of interferon-alpha production (GO:0032647) | 2.90453779 |
| 121 | ribosomal small subunit assembly (GO:0000028) | 2.89770391 |
| 122 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.89508207 |
| 123 | deoxyribonucleotide catabolic process (GO:0009264) | 2.88440052 |
| 124 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.88393735 |
| 125 | tryptophan catabolic process (GO:0006569) | 2.88322278 |
| 126 | indole-containing compound catabolic process (GO:0042436) | 2.88322278 |
| 127 | indolalkylamine catabolic process (GO:0046218) | 2.88322278 |
| 128 | negative regulation of B cell proliferation (GO:0030889) | 2.88234708 |
| 129 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.87773948 |
| 130 | L-fucose catabolic process (GO:0042355) | 2.87558556 |
| 131 | fucose catabolic process (GO:0019317) | 2.87558556 |
| 132 | L-fucose metabolic process (GO:0042354) | 2.87558556 |
| 133 | negative regulation of mast cell activation (GO:0033004) | 2.87537653 |
| 134 | regulation of gamma-delta T cell activation (GO:0046643) | 2.86575346 |
| 135 | mast cell activation (GO:0045576) | 2.84162518 |
| 136 | response to protozoan (GO:0001562) | 2.82171202 |
| 137 | mitotic metaphase plate congression (GO:0007080) | 2.80336347 |
| 138 | defense response to protozoan (GO:0042832) | 2.80152181 |
| 139 | cellular response to interferon-beta (GO:0035458) | 2.79679161 |
| 140 | nuclear pore complex assembly (GO:0051292) | 2.79305894 |
| 141 | interferon-gamma production (GO:0032609) | 2.79068943 |
| 142 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.78929528 |
| 143 | T cell costimulation (GO:0031295) | 2.77308640 |
| 144 | T-helper 1 type immune response (GO:0042088) | 2.76878886 |
| 145 | tolerance induction (GO:0002507) | 2.75778563 |
| 146 | lymphocyte costimulation (GO:0031294) | 2.75664483 |
| 147 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.75558933 |
| 148 | regulation of T-helper cell differentiation (GO:0045622) | 2.74414532 |
| 149 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.74130005 |
| 150 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.74040838 |
| 151 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.73623533 |
| 152 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.73110513 |
| 153 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.72644159 |
| 154 | cellular response to interferon-gamma (GO:0071346) | 2.71961277 |
| 155 | positive regulation of interleukin-2 production (GO:0032743) | 2.70452620 |
| 156 | regulation of DNA endoreduplication (GO:0032875) | 2.65655235 |
| 157 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.65065207 |
| 158 | kynurenine metabolic process (GO:0070189) | 2.62323069 |
| 159 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.58407861 |
| 160 | protein K6-linked ubiquitination (GO:0085020) | 2.56949199 |
| 161 | response to interleukin-15 (GO:0070672) | 2.54885472 |
| 162 | positive regulation by symbiont of host defense response (GO:0052509) | 2.53573116 |
| 163 | modulation by symbiont of host defense response (GO:0052031) | 2.53573116 |
| 164 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.53573116 |
| 165 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.53573116 |
| 166 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.53573116 |
| 167 | modulation by symbiont of host immune response (GO:0052553) | 2.53573116 |
| 168 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.53164194 |
| 169 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.52603708 |
| 170 | NIK/NF-kappaB signaling (GO:0038061) | 2.50585796 |
| 171 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.49770837 |
| 172 | NADH dehydrogenase complex assembly (GO:0010257) | 2.47716422 |
| 173 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.47716422 |
| 174 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.47716422 |
| 175 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.45949303 |
| 176 | protein K11-linked deubiquitination (GO:0035871) | 2.45748326 |
| 177 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.44403830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 9.25120140 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.99296650 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.65969434 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.40013806 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.35611300 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.83080003 |
| 7 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.79464574 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.53106485 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.47477090 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.44382962 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.14794254 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.14440698 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.87940267 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.87309835 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.74673849 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.61317427 |
| 17 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.59414927 |
| 18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.52495007 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.37321063 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.23798176 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.09186656 |
| 22 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.08800990 |
| 23 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.03806697 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.03313584 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.02788538 |
| 26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.02100952 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.96292599 |
| 28 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.95679831 |
| 29 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.92117770 |
| 30 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.91368182 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.85127492 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.77804640 |
| 33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.77547691 |
| 34 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.77446812 |
| 35 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.77410282 |
| 36 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.75918231 |
| 37 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.73939950 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.72210421 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.70574298 |
| 40 | GATA3_26560356_Chip-Seq_TH2_Human | 1.65750240 |
| 41 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.65264442 |
| 42 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.63076852 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.58550027 |
| 44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.58454998 |
| 45 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.56460101 |
| 46 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.56068210 |
| 47 | EWS_26573619_Chip-Seq_HEK293_Human | 1.55592182 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.54459028 |
| 49 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.53455174 |
| 50 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.53082766 |
| 51 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.50762531 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50211952 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49780476 |
| 54 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.49581815 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.47818536 |
| 56 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.45122187 |
| 57 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.43067393 |
| 58 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.42925143 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.42157324 |
| 60 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.41483826 |
| 61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.39308530 |
| 62 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.37788785 |
| 63 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.37759817 |
| 64 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.37214119 |
| 65 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.36330184 |
| 66 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.34571997 |
| 67 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.33092705 |
| 68 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.31610520 |
| 69 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.30924832 |
| 70 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.30483767 |
| 71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.28517187 |
| 72 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.28108307 |
| 73 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.27831825 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26519017 |
| 75 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.23786340 |
| 76 | UTX_26944678_Chip-Seq_JUKART_Human | 1.23682008 |
| 77 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.23252034 |
| 78 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.22459045 |
| 79 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.19699394 |
| 80 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.19607894 |
| 81 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.17878891 |
| 82 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.17538655 |
| 83 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.17171300 |
| 84 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14938307 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.14883119 |
| 86 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.14612838 |
| 87 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.14310112 |
| 88 | * GATA3_26560356_Chip-Seq_TH1_Human | 1.13413886 |
| 89 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.13222217 |
| 90 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.12463022 |
| 91 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.11991386 |
| 92 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.11448230 |
| 93 | MAF_26560356_Chip-Seq_TH2_Human | 1.11029134 |
| 94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10437779 |
| 95 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10239451 |
| 96 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.09391199 |
| 97 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.09391199 |
| 98 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.08262617 |
| 99 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06908560 |
| 100 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06581721 |
| 101 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.06144674 |
| 102 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05936403 |
| 103 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.05049547 |
| 104 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.04696776 |
| 105 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.04261231 |
| 106 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.02148475 |
| 107 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.01437229 |
| 108 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01254027 |
| 109 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01055936 |
| 110 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00701357 |
| 111 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.00176912 |
| 112 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.00113135 |
| 113 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.00013190 |
| 114 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.97326809 |
| 115 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97027277 |
| 116 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96903926 |
| 117 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.96102731 |
| 118 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95919564 |
| 119 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.95033115 |
| 120 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94348077 |
| 121 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.94336767 |
| 122 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.94040497 |
| 123 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.93770330 |
| 124 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.93423060 |
| 125 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.93195374 |
| 126 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93082896 |
| 127 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92698046 |
| 128 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.92491325 |
| 129 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91428133 |
| 130 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91214301 |
| 131 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90909130 |
| 132 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.90724201 |
| 133 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.90343003 |
| 134 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.90262122 |
| 135 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86268428 |
| 136 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.86021661 |
| 137 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.85153239 |
| 138 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.84583691 |
| 139 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.84348544 |
| 140 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83520533 |
| 141 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.82626124 |
| 142 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.82626124 |
| 143 | STAT3_23295773_ChIP-Seq_U87_Human | 0.82553754 |
| 144 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.82195140 |
| 145 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.81831565 |
| 146 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.81148568 |
| 147 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.76820554 |
| 148 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76311097 |
| 149 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76269936 |
| 150 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73681749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 6.04485005 |
| 2 | * MP0001800_abnormal_humoral_immune | 4.92611852 |
| 3 | MP0001790_abnormal_immune_system | 4.45812851 |
| 4 | MP0005387_immune_system_phenotype | 4.45812851 |
| 5 | MP0005645_abnormal_hypothalamus_physiol | 3.93569616 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 3.87639866 |
| 7 | MP0008057_abnormal_DNA_replication | 3.75217381 |
| 8 | MP0000685_abnormal_immune_system | 3.71482784 |
| 9 | * MP0002452_abnormal_antigen_presenting | 3.59973234 |
| 10 | MP0005671_abnormal_response_to | 3.43958104 |
| 11 | MP0005000_abnormal_immune_tolerance | 3.01746570 |
| 12 | * MP0002723_abnormal_immune_serum | 2.97058323 |
| 13 | * MP0002420_abnormal_adaptive_immunity | 2.95831880 |
| 14 | * MP0002398_abnormal_bone_marrow | 2.86151400 |
| 15 | * MP0001819_abnormal_immune_cell | 2.85802064 |
| 16 | MP0000372_irregular_coat_pigmentation | 2.80130421 |
| 17 | MP0008872_abnormal_physiological_respon | 2.68514728 |
| 18 | * MP0010094_abnormal_chromosome_stability | 2.68325578 |
| 19 | MP0000689_abnormal_spleen_morphology | 2.64570745 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.63553685 |
| 21 | * MP0000716_abnormal_immune_system | 2.54387815 |
| 22 | MP0003077_abnormal_cell_cycle | 2.45409732 |
| 23 | MP0004957_abnormal_blastocyst_morpholog | 2.39513274 |
| 24 | MP0003303_peritoneal_inflammation | 2.33845417 |
| 25 | MP0003763_abnormal_thymus_physiology | 2.31940952 |
| 26 | MP0000013_abnormal_adipose_tissue | 2.23283710 |
| 27 | MP0003111_abnormal_nucleus_morphology | 2.21688277 |
| 28 | MP0002722_abnormal_immune_system | 2.20574026 |
| 29 | MP0003693_abnormal_embryo_hatching | 2.14624104 |
| 30 | * MP0002429_abnormal_blood_cell | 2.14499907 |
| 31 | MP0001853_heart_inflammation | 2.10551613 |
| 32 | MP0005025_abnormal_response_to | 1.93775453 |
| 33 | MP0005310_abnormal_salivary_gland | 1.81655698 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.80512998 |
| 35 | MP0002163_abnormal_gland_morphology | 1.78488897 |
| 36 | MP0009046_muscle_twitch | 1.78176236 |
| 37 | MP0002933_joint_inflammation | 1.72549212 |
| 38 | MP0002928_abnormal_bile_duct | 1.70080417 |
| 39 | MP0004510_myositis | 1.63885229 |
| 40 | MP0008058_abnormal_DNA_repair | 1.62897821 |
| 41 | MP0009785_altered_susceptibility_to | 1.62760479 |
| 42 | MP0002139_abnormal_hepatobiliary_system | 1.61436065 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 1.56751888 |
| 44 | MP0002405_respiratory_system_inflammati | 1.52531349 |
| 45 | MP0002419_abnormal_innate_immunity | 1.43114922 |
| 46 | * MP0002019_abnormal_tumor_incidence | 1.37842408 |
| 47 | MP0000703_abnormal_thymus_morphology | 1.37583373 |
| 48 | MP0001348_abnormal_lacrimal_gland | 1.36160929 |
| 49 | MP0003252_abnormal_bile_duct | 1.35591193 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.34788786 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.34264601 |
| 52 | MP0004142_abnormal_muscle_tone | 1.27169229 |
| 53 | MP0010352_gastrointestinal_tract_polyps | 1.24653931 |
| 54 | MP0000350_abnormal_cell_proliferation | 1.22315577 |
| 55 | MP0001873_stomach_inflammation | 1.19584152 |
| 56 | MP0006292_abnormal_olfactory_placode | 1.18221721 |
| 57 | MP0004145_abnormal_muscle_electrophysio | 1.17290007 |
| 58 | MP0006082_CNS_inflammation | 1.17062597 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.15119491 |
| 60 | MP0005551_abnormal_eye_electrophysiolog | 1.14120246 |
| 61 | MP0004808_abnormal_hematopoietic_stem | 1.13807340 |
| 62 | MP0003436_decreased_susceptibility_to | 1.12314953 |
| 63 | MP0002876_abnormal_thyroid_physiology | 1.09602018 |
| 64 | MP0002693_abnormal_pancreas_physiology | 1.09268969 |
| 65 | MP0000313_abnormal_cell_death | 1.07208816 |
| 66 | MP0008007_abnormal_cellular_replicative | 1.05994549 |
| 67 | MP0002837_dystrophic_cardiac_calcinosis | 1.05547576 |
| 68 | MP0008961_abnormal_basal_metabolism | 1.00815718 |
| 69 | MP0005171_absent_coat_pigmentation | 1.00423990 |
| 70 | MP0002653_abnormal_ependyma_morphology | 0.97140019 |
| 71 | MP0004947_skin_inflammation | 0.96444170 |
| 72 | MP0004742_abnormal_vestibular_system | 0.96007358 |
| 73 | MP0001986_abnormal_taste_sensitivity | 0.95949691 |
| 74 | MP0000631_abnormal_neuroendocrine_gland | 0.95899355 |
| 75 | MP0000003_abnormal_adipose_tissue | 0.95863158 |
| 76 | MP0002735_abnormal_chemical_nociception | 0.95750219 |
| 77 | MP0001730_embryonic_growth_arrest | 0.93019493 |
| 78 | MP0005220_abnormal_exocrine_pancreas | 0.92579102 |
| 79 | MP0002102_abnormal_ear_morphology | 0.91376728 |
| 80 | MP0001968_abnormal_touch/_nociception | 0.88240784 |
| 81 | MP0006072_abnormal_retinal_apoptosis | 0.87744253 |
| 82 | MP0009745_abnormal_behavioral_response | 0.85592382 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 0.85545359 |
| 84 | MP0005253_abnormal_eye_physiology | 0.84357103 |
| 85 | MP0010155_abnormal_intestine_physiology | 0.84285524 |
| 86 | MP0008932_abnormal_embryonic_tissue | 0.84192548 |
| 87 | MP0003646_muscle_fatigue | 0.80638669 |
| 88 | MP0003787_abnormal_imprinting | 0.79155015 |
| 89 | MP0002006_tumorigenesis | 0.78519423 |
| 90 | MP0009333_abnormal_splenocyte_physiolog | 0.78303531 |
| 91 | MP0008875_abnormal_xenobiotic_pharmacok | 0.78125529 |
| 92 | MP0005646_abnormal_pituitary_gland | 0.78051902 |
| 93 | MP0000371_diluted_coat_color | 0.76767219 |
| 94 | MP0005379_endocrine/exocrine_gland_phen | 0.76725492 |
| 95 | MP0001944_abnormal_pancreas_morphology | 0.76712822 |
| 96 | MP0002272_abnormal_nervous_system | 0.76493021 |
| 97 | MP0005389_reproductive_system_phenotype | 0.73549922 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.73259370 |
| 99 | MP0002736_abnormal_nociception_after | 0.72364163 |
| 100 | MP0003866_abnormal_defecation | 0.71622969 |
| 101 | MP0000015_abnormal_ear_pigmentation | 0.67276745 |
| 102 | MP0003195_calcinosis | 0.66682366 |
| 103 | MP0000613_abnormal_salivary_gland | 0.65363342 |
| 104 | MP0001984_abnormal_olfaction | 0.65141425 |
| 105 | MP0003045_fibrosis | 0.64621125 |
| 106 | MP0005167_abnormal_blood-brain_barrier | 0.64556629 |
| 107 | MP0003786_premature_aging | 0.63675392 |
| 108 | MP0003300_gastrointestinal_ulcer | 0.62978765 |
| 109 | MP0001346_abnormal_lacrimal_gland | 0.62720326 |
| 110 | MP0003121_genomic_imprinting | 0.61385868 |
| 111 | MP0000490_abnormal_crypts_of | 0.60819100 |
| 112 | MP0005464_abnormal_platelet_physiology | 0.60219059 |
| 113 | MP0003011_delayed_dark_adaptation | 0.60210199 |
| 114 | MP0005332_abnormal_amino_acid | 0.59062298 |
| 115 | MP0003984_embryonic_growth_retardation | 0.57780381 |
| 116 | MP0001529_abnormal_vocalization | 0.57077597 |
| 117 | MP0008469_abnormal_protein_level | 0.57048676 |
| 118 | MP0005380_embryogenesis_phenotype | 0.55584587 |
| 119 | MP0001672_abnormal_embryogenesis/_devel | 0.55584587 |
| 120 | MP0008877_abnormal_DNA_methylation | 0.55415938 |
| 121 | MP0002088_abnormal_embryonic_growth/wei | 0.54163188 |
| 122 | MP0005023_abnormal_wound_healing | 0.53641654 |
| 123 | MP0010307_abnormal_tumor_latency | 0.52989327 |
| 124 | MP0009697_abnormal_copulation | 0.52405817 |
| 125 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.51864447 |
| 126 | * MP0002083_premature_death | 0.50938264 |
| 127 | MP0005621_abnormal_cell_physiology | 0.50842206 |
| 128 | MP0002095_abnormal_skin_pigmentation | 0.50483989 |
| 129 | * MP0001191_abnormal_skin_condition | 0.50381004 |
| 130 | MP0001697_abnormal_embryo_size | 0.49298643 |
| 131 | MP0006035_abnormal_mitochondrial_morpho | 0.48892767 |
| 132 | MP0002080_prenatal_lethality | 0.48798775 |
| 133 | MP0009764_decreased_sensitivity_to | 0.48482668 |
| 134 | MP0002132_abnormal_respiratory_system | 0.47527756 |
| 135 | MP0010234_abnormal_vibrissa_follicle | 0.46171025 |
| 136 | MP0005075_abnormal_melanosome_morpholog | 0.44608136 |
| 137 | MP0005384_cellular_phenotype | 0.43648822 |
| 138 | MP0001919_abnormal_reproductive_system | 0.43393480 |
| 139 | MP0000858_altered_metastatic_potential | 0.42885637 |
| 140 | MP0005257_abnormal_intraocular_pressure | 0.42045156 |
| 141 | MP0005266_abnormal_metabolism | 0.41392047 |
| 142 | MP0005394_taste/olfaction_phenotype | 0.40496698 |
| 143 | MP0005499_abnormal_olfactory_system | 0.40496698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.69470815 |
| 2 | Gastrointestinal stroma tumor (HP:0100723) | 8.69752223 |
| 3 | Recurrent sinusitis (HP:0011108) | 7.54754780 |
| 4 | Recurrent bronchitis (HP:0002837) | 6.98832769 |
| 5 | Cellulitis (HP:0100658) | 6.13002904 |
| 6 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 5.59956390 |
| 7 | Lymphopenia (HP:0001888) | 5.50383729 |
| 8 | Chronic sinusitis (HP:0011109) | 5.39967976 |
| 9 | Recurrent pneumonia (HP:0006532) | 5.37625751 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.07832206 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 4.90555480 |
| 12 | Emphysema (HP:0002097) | 4.86448102 |
| 13 | * Recurrent lower respiratory tract infections (HP:0002783) | 4.65344272 |
| 14 | Verrucae (HP:0200043) | 4.63132770 |
| 15 | Papilloma (HP:0012740) | 4.63132770 |
| 16 | Vasculitis (HP:0002633) | 4.47209491 |
| 17 | IgM deficiency (HP:0002850) | 4.39662772 |
| 18 | Bronchitis (HP:0012387) | 4.30064282 |
| 19 | Colitis (HP:0002583) | 4.26205041 |
| 20 | Meningitis (HP:0001287) | 4.20973920 |
| 21 | Recurrent viral infections (HP:0004429) | 3.86286509 |
| 22 | Osteomyelitis (HP:0002754) | 3.85092001 |
| 23 | Recurrent otitis media (HP:0000403) | 3.79797460 |
| 24 | Panhypogammaglobulinemia (HP:0003139) | 3.78408594 |
| 25 | Restrictive lung disease (HP:0002091) | 3.74031030 |
| 26 | Inflammation of the large intestine (HP:0002037) | 3.54547344 |
| 27 | Abnormality of T cell physiology (HP:0011840) | 3.51659759 |
| 28 | Leukopenia (HP:0001882) | 3.42589433 |
| 29 | Gastrointestinal inflammation (HP:0004386) | 3.38751634 |
| 30 | Chronic otitis media (HP:0000389) | 3.34515378 |
| 31 | Multiple enchondromatosis (HP:0005701) | 3.22542828 |
| 32 | Lymphoma (HP:0002665) | 3.14551030 |
| 33 | B lymphocytopenia (HP:0010976) | 3.11765039 |
| 34 | Abnormality of B cell number (HP:0010975) | 3.11765039 |
| 35 | Sepsis (HP:0100806) | 3.08472824 |
| 36 | * IgG deficiency (HP:0004315) | 2.99191609 |
| 37 | Chronic diarrhea (HP:0002028) | 2.97778136 |
| 38 | Pancreatic cysts (HP:0001737) | 2.94569518 |
| 39 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.93966456 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 2.93966456 |
| 41 | Thyroiditis (HP:0100646) | 2.87464330 |
| 42 | Pendular nystagmus (HP:0012043) | 2.81627102 |
| 43 | Chronic hepatic failure (HP:0100626) | 2.78015202 |
| 44 | Recurrent abscess formation (HP:0002722) | 2.77789646 |
| 45 | Skin rash (HP:0000988) | 2.76173384 |
| 46 | Small epiphyses (HP:0010585) | 2.72196210 |
| 47 | Abnormality of T cells (HP:0002843) | 2.71063093 |
| 48 | Viral hepatitis (HP:0006562) | 2.69831244 |
| 49 | Recurrent fungal infections (HP:0002841) | 2.69469487 |
| 50 | Limb hypertonia (HP:0002509) | 2.66716627 |
| 51 | Molar tooth sign on MRI (HP:0002419) | 2.66459500 |
| 52 | Abnormality of midbrain morphology (HP:0002418) | 2.66459500 |
| 53 | Chromsome breakage (HP:0040012) | 2.64483715 |
| 54 | Recurrent bacterial skin infections (HP:0005406) | 2.62534170 |
| 55 | Congenital stationary night blindness (HP:0007642) | 2.61595394 |
| 56 | Increased IgM level (HP:0003496) | 2.60360551 |
| 57 | Hypochromic anemia (HP:0001931) | 2.60091226 |
| 58 | Autoimmune hemolytic anemia (HP:0001890) | 2.55133714 |
| 59 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.52068298 |
| 60 | Combined immunodeficiency (HP:0005387) | 2.50465705 |
| 61 | True hermaphroditism (HP:0010459) | 2.48132869 |
| 62 | Squamous cell carcinoma (HP:0002860) | 2.47619598 |
| 63 | Attenuation of retinal blood vessels (HP:0007843) | 2.40660851 |
| 64 | 3-Methylglutaconic aciduria (HP:0003535) | 2.35969077 |
| 65 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.35812927 |
| 66 | Abnormality of the renal collecting system (HP:0004742) | 2.35803813 |
| 67 | Eosinophilia (HP:0001880) | 2.35300466 |
| 68 | Pancreatic fibrosis (HP:0100732) | 2.35248889 |
| 69 | Nasal polyposis (HP:0100582) | 2.34745713 |
| 70 | Encephalitis (HP:0002383) | 2.34055136 |
| 71 | Abnormality of the renal cortex (HP:0011035) | 2.31948142 |
| 72 | Abnormal lung lobation (HP:0002101) | 2.31284890 |
| 73 | Type II lissencephaly (HP:0007260) | 2.29040287 |
| 74 | Recurrent skin infections (HP:0001581) | 2.25874160 |
| 75 | Abnormality of T cell number (HP:0011839) | 2.25530572 |
| 76 | Neutropenia (HP:0001875) | 2.25405800 |
| 77 | Nephronophthisis (HP:0000090) | 2.24710745 |
| 78 | Abnormal pancreas size (HP:0012094) | 2.24055781 |
| 79 | Carpal bone hypoplasia (HP:0001498) | 2.23554630 |
| 80 | Abnormality of DNA repair (HP:0003254) | 2.23510700 |
| 81 | Duplicated collecting system (HP:0000081) | 2.19181939 |
| 82 | Basal cell carcinoma (HP:0002671) | 2.16669589 |
| 83 | Mediastinal lymphadenopathy (HP:0100721) | 2.15668343 |
| 84 | Conical tooth (HP:0000698) | 2.15396141 |
| 85 | Pulmonary infiltrates (HP:0002113) | 2.14657875 |
| 86 | Birth length less than 3rd percentile (HP:0003561) | 2.12662077 |
| 87 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.11798817 |
| 88 | Hypoplasia of the uterus (HP:0000013) | 2.11796354 |
| 89 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.10488571 |
| 90 | Hypothermia (HP:0002045) | 2.09976674 |
| 91 | Renal cortical cysts (HP:0000803) | 2.07795823 |
| 92 | Inability to walk (HP:0002540) | 2.06632869 |
| 93 | Bronchiectasis (HP:0002110) | 2.06104206 |
| 94 | Hypoplasia of the pons (HP:0012110) | 2.05849343 |
| 95 | Eczematoid dermatitis (HP:0000976) | 2.05754639 |
| 96 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.05169717 |
| 97 | Abnormality of the pons (HP:0007361) | 2.03598290 |
| 98 | Methylmalonic acidemia (HP:0002912) | 2.03172430 |
| 99 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.02189572 |
| 100 | Villous atrophy (HP:0011473) | 2.02189572 |
| 101 | Tubular atrophy (HP:0000092) | 2.01063690 |
| 102 | Granulocytopenia (HP:0001913) | 2.00144342 |
| 103 | * IgA deficiency (HP:0002720) | 1.99031224 |
| 104 | Abnormality of chromosome stability (HP:0003220) | 1.97915090 |
| 105 | Asplenia (HP:0001746) | 1.96750955 |
| 106 | Lissencephaly (HP:0001339) | 1.96521144 |
| 107 | Abnormality of the preputium (HP:0100587) | 1.96470468 |
| 108 | Increased corneal curvature (HP:0100692) | 1.96389063 |
| 109 | Keratoconus (HP:0000563) | 1.96389063 |
| 110 | Paralysis (HP:0003470) | 1.96065422 |
| 111 | Abnormality of the fingertips (HP:0001211) | 1.95957429 |
| 112 | Methylmalonic aciduria (HP:0012120) | 1.95639583 |
| 113 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.94242765 |
| 114 | Progressive inability to walk (HP:0002505) | 1.92909069 |
| 115 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.91655402 |
| 116 | Skin ulcer (HP:0200042) | 1.91601700 |
| 117 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.91374661 |
| 118 | Abnormality of male internal genitalia (HP:0000022) | 1.91368964 |
| 119 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.90565651 |
| 120 | Lipid accumulation in hepatocytes (HP:0006561) | 1.90073262 |
| 121 | Abolished electroretinogram (ERG) (HP:0000550) | 1.87776174 |
| 122 | Abnormality of the carotid arteries (HP:0005344) | 1.86961758 |
| 123 | Arthralgia (HP:0002829) | 1.86607845 |
| 124 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.85427459 |
| 125 | Absent epiphyses (HP:0010577) | 1.85427459 |
| 126 | Myelodysplasia (HP:0002863) | 1.84583058 |
| 127 | Abnormality of the renal medulla (HP:0100957) | 1.84176370 |
| 128 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.83727268 |
| 129 | Meckel diverticulum (HP:0002245) | 1.83558570 |
| 130 | Absent thumb (HP:0009777) | 1.83129091 |
| 131 | Chronic obstructive pulmonary disease (HP:0006510) | 1.82631952 |
| 132 | Obstructive lung disease (HP:0006536) | 1.82631952 |
| 133 | Gaze-evoked nystagmus (HP:0000640) | 1.82017288 |
| 134 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.80465517 |
| 135 | Increased CSF lactate (HP:0002490) | 1.79234785 |
| 136 | Hypergammaglobulinemia (HP:0010702) | 1.77549245 |
| 137 | Mitochondrial inheritance (HP:0001427) | 1.75151403 |
| 138 | Abnormality of the prostate (HP:0008775) | 1.75063609 |
| 139 | Sloping forehead (HP:0000340) | 1.75044125 |
| 140 | Hyperglycinuria (HP:0003108) | 1.75025758 |
| 141 | Abnormality of the ileum (HP:0001549) | 1.74496214 |
| 142 | Increased IgE level (HP:0003212) | 1.73922519 |
| 143 | Small intestinal stenosis (HP:0012848) | 1.73077293 |
| 144 | Duodenal stenosis (HP:0100867) | 1.73077293 |
| 145 | Volvulus (HP:0002580) | 1.72469860 |
| 146 | Abnormality of the nasal mucosa (HP:0000433) | 1.72459777 |
| 147 | Papilledema (HP:0001085) | 1.71096596 |
| 148 | Progressive cerebellar ataxia (HP:0002073) | 1.70535489 |
| 149 | Embryonal renal neoplasm (HP:0011794) | 1.69489737 |
| 150 | Increased nuchal translucency (HP:0010880) | 1.68961525 |
| 151 | Abnormality of eosinophils (HP:0001879) | 1.68722623 |
| 152 | Abnormal number of erythroid precursors (HP:0012131) | 1.66951605 |
| 153 | Clubbing of toes (HP:0100760) | 1.66390548 |
| 154 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.65000072 |
| 155 | Hyperalaninemia (HP:0003348) | 1.63798289 |
| 156 | Leukocytosis (HP:0001974) | 1.61043431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 6.67662453 |
| 2 | BLK | 4.11448583 |
| 3 | CSF1R | 3.94904191 |
| 4 | SYK | 3.60475283 |
| 5 | ERN1 | 3.57019363 |
| 6 | FRK | 3.12826454 |
| 7 | GRK6 | 3.04189943 |
| 8 | BUB1 | 3.00754179 |
| 9 | CDC7 | 2.91162471 |
| 10 | TAOK3 | 2.86563975 |
| 11 | ZAK | 2.86484227 |
| 12 | CDK12 | 2.63423507 |
| 13 | BTK | 2.28398323 |
| 14 | KIT | 2.23558696 |
| 15 | LYN | 2.23214705 |
| 16 | STK10 | 2.12081292 |
| 17 | CCNB1 | 1.93635040 |
| 18 | TAF1 | 1.89418028 |
| 19 | BMPR1B | 1.89162943 |
| 20 | GRK1 | 1.86705016 |
| 21 | MST4 | 1.74165867 |
| 22 | NUAK1 | 1.74080886 |
| 23 | RIPK4 | 1.71197009 |
| 24 | NEK9 | 1.67054766 |
| 25 | PASK | 1.64254841 |
| 26 | CLK1 | 1.58238379 |
| 27 | BCKDK | 1.56232279 |
| 28 | NEK2 | 1.50857362 |
| 29 | EIF2AK3 | 1.49886973 |
| 30 | BCR | 1.44117276 |
| 31 | MAP4K2 | 1.39945000 |
| 32 | ITK | 1.36817670 |
| 33 | EIF2AK1 | 1.35951903 |
| 34 | MAP3K14 | 1.35902539 |
| 35 | EPHA3 | 1.34835563 |
| 36 | MAP3K10 | 1.32247859 |
| 37 | TEC | 1.25978417 |
| 38 | BRSK1 | 1.19332046 |
| 39 | GRK5 | 1.15588627 |
| 40 | LRRK2 | 1.13714470 |
| 41 | STK38L | 1.05376806 |
| 42 | PRPF4B | 1.05044723 |
| 43 | STK24 | 1.01671909 |
| 44 | PIM1 | 1.01450564 |
| 45 | MAPK7 | 0.99622730 |
| 46 | IKBKB | 0.99134504 |
| 47 | BMPR2 | 0.95898964 |
| 48 | MAPK11 | 0.95232370 |
| 49 | TBK1 | 0.94143115 |
| 50 | RPS6KA5 | 0.94134713 |
| 51 | MATK | 0.92524354 |
| 52 | SIK3 | 0.91940500 |
| 53 | TESK2 | 0.91535044 |
| 54 | MAP3K4 | 0.91438670 |
| 55 | CSK | 0.91005127 |
| 56 | LCK | 0.90174015 |
| 57 | CHEK2 | 0.89951040 |
| 58 | TNIK | 0.88542494 |
| 59 | ALK | 0.88272163 |
| 60 | HCK | 0.87332693 |
| 61 | ACVR1B | 0.87236372 |
| 62 | TTK | 0.86905247 |
| 63 | ATR | 0.85707441 |
| 64 | ZAP70 | 0.83779840 |
| 65 | PLK1 | 0.81811269 |
| 66 | MKNK2 | 0.80854093 |
| 67 | CSNK1G3 | 0.79031598 |
| 68 | WNK3 | 0.78942283 |
| 69 | MAPK13 | 0.78106408 |
| 70 | CHEK1 | 0.77538578 |
| 71 | PTK2B | 0.77307401 |
| 72 | TGFBR1 | 0.77204167 |
| 73 | TGFBR2 | 0.76814604 |
| 74 | OXSR1 | 0.75298723 |
| 75 | FGFR3 | 0.74353234 |
| 76 | AURKB | 0.73644162 |
| 77 | JAK3 | 0.73375998 |
| 78 | ADRBK2 | 0.72870139 |
| 79 | IRAK4 | 0.72590939 |
| 80 | CSNK1A1L | 0.72545341 |
| 81 | PLK4 | 0.71124096 |
| 82 | BRSK2 | 0.71075038 |
| 83 | CDC42BPA | 0.70965090 |
| 84 | * PRKCQ | 0.70101034 |
| 85 | CSNK1G1 | 0.68921853 |
| 86 | RPS6KA4 | 0.68808242 |
| 87 | VRK2 | 0.68560699 |
| 88 | EIF2AK2 | 0.68329878 |
| 89 | WEE1 | 0.64560105 |
| 90 | TXK | 0.64435003 |
| 91 | INSRR | 0.64286635 |
| 92 | MAPKAPK3 | 0.64243439 |
| 93 | SRPK1 | 0.63100229 |
| 94 | PKN1 | 0.61978739 |
| 95 | FES | 0.59719598 |
| 96 | MAP3K13 | 0.58985289 |
| 97 | MAPKAPK5 | 0.58309588 |
| 98 | TYK2 | 0.58127512 |
| 99 | NME1 | 0.57287105 |
| 100 | PIM2 | 0.57194659 |
| 101 | CDK4 | 0.56766210 |
| 102 | CDK19 | 0.56483890 |
| 103 | * PRKCD | 0.55685696 |
| 104 | MAPK12 | 0.55273308 |
| 105 | MELK | 0.54036427 |
| 106 | CDK7 | 0.51876207 |
| 107 | VRK1 | 0.50266382 |
| 108 | MAP2K7 | 0.47930036 |
| 109 | STK3 | 0.47814819 |
| 110 | INSR | 0.47295534 |
| 111 | HIPK2 | 0.45551472 |
| 112 | IRAK1 | 0.45427937 |
| 113 | AURKA | 0.43851045 |
| 114 | MAP3K9 | 0.43769151 |
| 115 | DAPK3 | 0.41807416 |
| 116 | DAPK2 | 0.40910835 |
| 117 | STK4 | 0.40145071 |
| 118 | SIK2 | 0.40111268 |
| 119 | IKBKE | 0.39860116 |
| 120 | MARK3 | 0.39789257 |
| 121 | BRD4 | 0.39454337 |
| 122 | ABL1 | 0.38355520 |
| 123 | CSNK1G2 | 0.38336329 |
| 124 | FYN | 0.37837807 |
| 125 | MAPKAPK2 | 0.37689293 |
| 126 | ATM | 0.37128609 |
| 127 | SMG1 | 0.36633526 |
| 128 | MAP2K2 | 0.36507407 |
| 129 | CDK2 | 0.36481417 |
| 130 | JAK1 | 0.35779303 |
| 131 | SGK2 | 0.33621664 |
| 132 | CSNK2A1 | 0.32772458 |
| 133 | CHUK | 0.32473737 |
| 134 | PDK1 | 0.31370469 |
| 135 | CSNK1A1 | 0.29478081 |
| 136 | CSNK1D | 0.29322917 |
| 137 | TNK2 | 0.29194410 |
| 138 | CDK9 | 0.29041014 |
| 139 | PAK3 | 0.27063879 |
| 140 | CDK8 | 0.25716064 |
| 141 | CSNK2A2 | 0.25491278 |
| 142 | IGF1R | 0.25442093 |
| 143 | NEK1 | 0.24200600 |
| 144 | CDK1 | 0.23297160 |
| 145 | DYRK1A | 0.22354883 |
| 146 | GRK7 | 0.21289632 |
| 147 | TLK1 | 0.18971707 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 5.71306269 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.93616589 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 4.80515043 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 4.70776716 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.34847913 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 2.96159972 |
| 7 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.61265650 |
| 8 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.56605100 |
| 9 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.43029847 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.34782181 |
| 11 | Proteasome_Homo sapiens_hsa03050 | 2.17371374 |
| 12 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.07679430 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.98099374 |
| 14 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.94410065 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.86893567 |
| 16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.81783876 |
| 17 | Cell cycle_Homo sapiens_hsa04110 | 1.68148159 |
| 18 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.68053125 |
| 19 | Spliceosome_Homo sapiens_hsa03040 | 1.67774600 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.66220258 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.59777622 |
| 22 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.49308224 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.37732935 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.34898141 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.33199818 |
| 26 | Allograft rejection_Homo sapiens_hsa05330 | 1.31776470 |
| 27 | RNA polymerase_Homo sapiens_hsa03020 | 1.28146800 |
| 28 | RNA transport_Homo sapiens_hsa03013 | 1.27590374 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.25286379 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21429809 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.20606909 |
| 32 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.17568989 |
| 33 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.17017649 |
| 34 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.13180361 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.10738684 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.10261284 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.09773601 |
| 38 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08857695 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.04983378 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03156953 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.01202013 |
| 42 | Leishmaniasis_Homo sapiens_hsa05140 | 0.98096225 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.97551812 |
| 44 | RNA degradation_Homo sapiens_hsa03018 | 0.97120269 |
| 45 | Alcoholism_Homo sapiens_hsa05034 | 0.95910746 |
| 46 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95575124 |
| 47 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.95104363 |
| 48 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.94050206 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92631672 |
| 50 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91994217 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.91163086 |
| 52 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.89484495 |
| 53 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88259903 |
| 54 | Protein export_Homo sapiens_hsa03060 | 0.86812906 |
| 55 | Measles_Homo sapiens_hsa05162 | 0.84872498 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.83928918 |
| 57 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.83803348 |
| 58 | Basal transcription factors_Homo sapiens_hsa03022 | 0.83652312 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.83453676 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83030073 |
| 61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.82769755 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 0.81209613 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.79230588 |
| 64 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.78836332 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.77689518 |
| 66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.77119708 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75445629 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.74102072 |
| 69 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.70154512 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.69708569 |
| 71 | Hepatitis B_Homo sapiens_hsa05161 | 0.66752324 |
| 72 | Influenza A_Homo sapiens_hsa05164 | 0.64782822 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64111914 |
| 74 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.62832328 |
| 75 | Purine metabolism_Homo sapiens_hsa00230 | 0.61377318 |
| 76 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.60131815 |
| 77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58906494 |
| 78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57868624 |
| 79 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54505368 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.52607641 |
| 81 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.51588673 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.49874610 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49300861 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.46859488 |
| 85 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.46770878 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46434119 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46337155 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.41806987 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40936820 |
| 90 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.40172916 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38958648 |
| 92 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.37580559 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36975001 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36560857 |
| 95 | Salmonella infection_Homo sapiens_hsa05132 | 0.36379341 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35991540 |
| 97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.34383118 |
| 98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.34165301 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33459115 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.33079560 |
| 101 | Nicotine addiction_Homo sapiens_hsa05033 | 0.32747207 |
| 102 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32322738 |
| 103 | Olfactory transduction_Homo sapiens_hsa04740 | 0.32203536 |
| 104 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.30599328 |
| 105 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.28134119 |
| 106 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.26519714 |
| 107 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.26368875 |
| 108 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.25893919 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25462838 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | 0.25248461 |
| 111 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.24576070 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.23717224 |
| 113 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23608398 |
| 114 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.22996117 |
| 115 | Pertussis_Homo sapiens_hsa05133 | 0.22400331 |
| 116 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.21934582 |
| 117 | Morphine addiction_Homo sapiens_hsa05032 | 0.20514763 |
| 118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.18283065 |
| 119 | Huntingtons disease_Homo sapiens_hsa05016 | 0.18212906 |
| 120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.17524324 |
| 121 | Peroxisome_Homo sapiens_hsa04146 | 0.15520141 |
| 122 | Lysine degradation_Homo sapiens_hsa00310 | 0.15311965 |
| 123 | Platelet activation_Homo sapiens_hsa04611 | 0.15177555 |
| 124 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.14936166 |
| 125 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.14327084 |
| 126 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.14189221 |
| 127 | Alzheimers disease_Homo sapiens_hsa05010 | 0.12270854 |
| 128 | ABC transporters_Homo sapiens_hsa02010 | 0.11826263 |
| 129 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.10085145 |
| 130 | Malaria_Homo sapiens_hsa05144 | 0.09235903 |
| 131 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.08889776 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.08689401 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.07573719 |
| 134 | Pathways in cancer_Homo sapiens_hsa05200 | 0.05508599 |
| 135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.04990811 |
| 136 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.04376235 |
| 137 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.04080333 |
| 138 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.02867982 |
| 139 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.02107724 |
| 140 | Colorectal cancer_Homo sapiens_hsa05210 | 0.01417569 |

